SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant

One of the features distinguishing SARS-CoV-2 from its more pathogenic counterpart SARS-CoV is the presence of premature stop codons in its ORF3b gene. Here, we show that SARS-CoV-2 ORF3b is a potent interferon antagonist, suppressing the induction of type I interferon more efficiently than its SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: Konno, Yoriyuki, Kimura, Izumi, Uriu, Keiya, Fukushi, Masaya, Irie, Takashi, Koyanagi, Yoshio, Sauter, Daniel, Gifford, Robert J., Nakagawa, So, Sato, Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. 2020
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473339/
https://www.ncbi.nlm.nih.gov/pubmed/32941788
http://dx.doi.org/10.1016/j.celrep.2020.108185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473339/
https://www.ncbi.nlm.nih.gov/pubmed/32941788
http://dx.doi.org/10.1016/j.celrep.2020.108185

Ejemplares similares